Literature DB >> 29351354

The Effects of Intensive Speech Treatment on Conversational Intelligibility in Spanish Speakers With Parkinson's Disease.

Gemma Moya-Galé1,2, Alireza Goudarzi3, Àngels Bayés2, Megan McAuliffe4, Bram Bulté5, Erika S Levy1.   

Abstract

Purpose: The purpose of this study was to examine the effects of intensive speech treatment on the conversational intelligibility of Castilian Spanish speakers with Parkinson's disease (PD), as well as on the speakers' self-perceptions of disability. Method: Fifteen speakers with a medical diagnosis of PD participated in this study. Speech recordings were completed twice before treatment, immediately posttreatment, and at a 1-month follow-up session. Conversational intelligibility was assessed in 2 ways-transcription accuracy scores and intelligibility ratings on a 9-point Likert scale. The Voice Handicap Index (Núñez-Batalla et al., 2007) was administered as a measure of self-perceived disability.
Results: Group data revealed that transcription accuracy and median ease-of-understanding ratings increased significantly immediately posttreatment, with gains maintained at the 1-month follow-up. The functional subscale of the Voice Handicap Index decreased significantly posttreatment, suggesting a decrease in perceived communication disability after speech treatment.
Conclusion: These findings support the implementation of intensive voice treatment to improve conversational intelligibility in Spanish speakers with PD with dysarthria as well as to improve the speakers' perception of their daily communicative capabilities. Clinical and theoretical considerations are discussed.

Entities:  

Mesh:

Year:  2018        PMID: 29351354     DOI: 10.1044/2017_AJSLP-17-0032

Source DB:  PubMed          Journal:  Am J Speech Lang Pathol        ISSN: 1058-0360            Impact factor:   2.408


  7 in total

1.  The Acoustic Voice Quality Index (AVQI) in People with Parkinson's Disease Before and After Intensive Voice and Articulation Therapies: Secondary Outcome of a Randomized Controlled Trial.

Authors:  Gemma Moya-Galé; Jennifer Spielman; Lorraine A Ramig; Luca Campanelli; Youri Maryn
Journal:  J Voice       Date:  2022-04-18       Impact factor: 2.300

2.  Intelligibility Across a Reading Passage: The Effect of Dysarthria and Cued Speaking Styles.

Authors:  Frits van Brenk; Kaila Stipancic; Alexander Kain; Kris Tjaden
Journal:  Am J Speech Lang Pathol       Date:  2022-01-04       Impact factor: 4.018

3.  Using Crowdsourced Listeners' Ratings to Measure Speech Changes in Hypokinetic Dysarthria: A Proof-of-Concept Study.

Authors:  Christopher Nightingale; Michelle Swartz; Lorraine Olson Ramig; Tara McAllister
Journal:  Am J Speech Lang Pathol       Date:  2020-04-24       Impact factor: 2.408

4.  The effects of intensive speech treatment on intelligibility in Parkinson's disease: A randomised controlled trial.

Authors:  Erika S Levy; Gemma Moya-Galé; Young Hwa M Chang; Katherine Freeman; Karen Forrest; Mitchell F Brin; Lorraine A Ramig
Journal:  EClinicalMedicine       Date:  2020-06-28

5.  Single Word Intelligibility of Individuals with Parkinson's Disease in Noise: Pre-Specified Secondary Outcome Variables from a Randomized Control Trial (RCT) Comparing Two Intensive Speech Treatments (LSVT LOUD vs. LSVT ARTIC).

Authors:  Geralyn Schulz; Angela Halpern; Jennifer Spielman; Lorraine Ramig; Ira Panzer; Alan Sharpley; Katherine Freeman
Journal:  Brain Sci       Date:  2021-06-27

6.  Automatic Speech Recognition in Noise for Parkinson's Disease: A Pilot Study.

Authors:  Alireza Goudarzi; Gemma Moya-Galé
Journal:  Front Artif Intell       Date:  2021-12-22

7.  Effectiveness of Lee Silverman Voice Treatment® LOUD on Japanese-Speaking Patients with Parkinson's Disease.

Authors:  Keigo Nakayama; Toshiyuki Yamamoto; Chihiro Oda; Masako Sato; Takeshi Murakami; Satoshi Horiguchi
Journal:  Rehabil Res Pract       Date:  2020-01-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.